Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 11 de 11
Filtrar
Más filtros












Base de datos
Intervalo de año de publicación
1.
mBio ; 8(4)2017 07 05.
Artículo en Inglés | MEDLINE | ID: mdl-28679748

RESUMEN

Staphylococcus argenteus is a newly named species previously described as a divergent lineage of Staphylococcus aureus that has recently been shown to have a global distribution. Despite growing evidence of the clinical importance of this species, knowledge about its population epidemiology and genomic architecture is limited. We used whole-genome sequencing to evaluate and compare S. aureus (n = 251) and S. argenteus (n = 68) isolates from adults with staphylococcal sepsis at several hospitals in northeastern Thailand between 2006 and 2013. The majority (82%) of the S. argenteus isolates were of multilocus sequence type 2250 (ST2250). S. aureus was more diverse, although 43% of the isolates belonged to ST121. Bayesian analysis suggested an S. argenteus ST2250 substitution rate of 4.66 (95% confidence interval [CI], 3.12 to 6.38) mutations per genome per year, which was comparable to the S. aureus ST121 substitution rate of 4.07 (95% CI, 2.61 to 5.55). S. argenteus ST2250 emerged in Thailand an estimated 15 years ago, which contrasts with the S. aureus ST1, ST88, and ST121 clades that emerged around 100 to 150 years ago. Comparison of S. argenteus ST2250 genomes from Thailand and a global collection indicated a single introduction into Thailand, followed by transmission to local and more distant countries in Southeast Asia and further afield. S. argenteus and S. aureus shared around half of their core gene repertoire, indicating a high level of divergence and providing strong support for their classification as separate species. Several gene clusters were present in ST2250 isolates but absent from the other S. argenteus and S. aureus study isolates. These included multiple exotoxins and antibiotic resistance genes that have been linked previously with livestock-associated S. aureus, consistent with a livestock reservoir for S. argenteus These genes appeared to be associated with plasmids and mobile genetic elements and may have contributed to the biological success of ST2250.IMPORTANCE In this study, we used whole-genome sequencing to understand the genome evolution and population structure of a systematic collection of ST2250 S. argenteus isolates. A newly identified ancestral species of S. aureus, S. argenteus has become increasingly known as a clinically important species that has been reported recently across various countries. Our results indicate that S. argenteus has spread at a relatively rapid pace over the past 2 decades across northeastern Thailand and acquired multiple exotoxin and antibiotic resistance genes that have been linked previously with livestock-associated S. aureus Our findings highlight the clinical importance and potential pathogenicity of S. argenteus as a recently emerging pathogen.


Asunto(s)
Evolución Molecular , Ganado/microbiología , Infecciones Estafilocócicas/microbiología , Staphylococcus aureus/genética , Staphylococcus/genética , Adulto , Animales , Antibacterianos/farmacología , Teorema de Bayes , Reservorios de Enfermedades/microbiología , Farmacorresistencia Bacteriana Múltiple/genética , Variación Genética , Genoma Bacteriano , Secuenciación de Nucleótidos de Alto Rendimiento/métodos , Humanos , Pruebas de Sensibilidad Microbiana , Tipificación de Secuencias Multilocus , Mutación , Sepsis/microbiología , Infecciones Estafilocócicas/epidemiología , Infecciones Estafilocócicas/transmisión , Staphylococcus/clasificación , Staphylococcus/efectos de los fármacos , Staphylococcus/aislamiento & purificación , Staphylococcus aureus/efectos de los fármacos , Staphylococcus aureus/aislamiento & purificación , Tailandia , Factores de Virulencia/genética
2.
Am J Trop Med Hyg ; 96(5): 1042-1049, 2017 May.
Artículo en Inglés | MEDLINE | ID: mdl-28167592

RESUMEN

AbstractStaphylococcus aureus infection is a persistent threat in resource-restricted settings in southeast Asia but informative data about this disease remain limited. We analyzed characteristics, management, and predictors of outcome in severely septic patients with community-onset S. aureus infection in northeast Thailand. We performed a prospective, multicenter observational cohort study of community-onset S. aureus sepsis in four referral hospitals recruiting patients at least 14 years of age admitted between March 2010 and December 2013. One hundred and nineteen patients with severe staphylococcal sepsis were enrolled. Diabetes was the most common underlying condition. Methicillin-resistant infection was rare. Twenty-eight-day mortality was 20%. Ninety-two percent of patients received appropriate antibiotic therapy and 82% were administered intravenous fluids on the first hospital day, although only 14% were managed in an intensive care unit (ICU). On univariable analysis, clinical variables at enrollment significantly associated with death at 28 days were coagulopathy or respiratory failure. Plasma interleukin (IL)-8 concentration alone accurately predicted mortality (area under the receiver operating curve = 0.82, 95% confidence interval = 0.73-0.90). In multivariable analysis, addition of IL-8 concentration to a mortality prediction model containing clinical variables further improved the predictive ability of the model. We conclude that severe staphylococcal sepsis in northeast Thailand causes significant mortality. Diabetes is a common preexisting condition and most patients are managed outside the ICU even if they receive vasoactive/inotropic agents or mechanical ventilation. While clinical factors apparent on presentation including coagulopathy and respiratory failure predict death, plasma IL-8 improves this prediction.


Asunto(s)
Antibacterianos/uso terapéutico , Fluidoterapia/métodos , Sepsis/terapia , Infecciones Estafilocócicas/terapia , Staphylococcus aureus/aislamiento & purificación , Anciano , Biomarcadores/sangre , Infecciones Comunitarias Adquiridas , Diabetes Mellitus/diagnóstico , Diabetes Mellitus/fisiopatología , Manejo de la Enfermedad , Coagulación Intravascular Diseminada/mortalidad , Femenino , Humanos , Unidades de Cuidados Intensivos/estadística & datos numéricos , Interleucina-8/sangre , Masculino , Persona de Mediana Edad , Pronóstico , Estudios Prospectivos , Insuficiencia Respiratoria/mortalidad , Sepsis/diagnóstico , Sepsis/microbiología , Sepsis/mortalidad , Infecciones Estafilocócicas/diagnóstico , Infecciones Estafilocócicas/microbiología , Infecciones Estafilocócicas/mortalidad , Staphylococcus aureus/efectos de los fármacos , Staphylococcus aureus/patogenicidad , Análisis de Supervivencia , Centros de Atención Terciaria , Tailandia
4.
Med Microbiol Immunol ; 205(3): 255-60, 2016 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-26563410

RESUMEN

Burkholderia pseudomallei, a gram-negative intracellular bacterium, is a causative agent of melioidosis. The bacterium has been shown to induce the innate immune response, particularly pro-inflammatory cytokine production in several of both mouse and human cell types. In the present study, we investigate host immune response in B. pseudomallei-infected primary human monocytes. We discover that wild-type B. pseudomallei is able to survive and multiply inside the primary human monocytes. In contrast, B. pseudomallei LPS mutant, a less virulent strain, is susceptible to host killing during bacterial infection. Moreover, microarray result showed that wild-type B. pseudomallei but not B. pseudomallei LPS mutant is able to activate gene expression of IL-23 as demonstrated by the up-regulation of p19 and p40 subunit expression. Consistent with gene expression analysis, the secretion of IL-23 analyzed by ELISA also showed that wild-type B. pseudomallei induces a significantly higher level of IL-23 secretion than that of B. pseudomallei LPS mutant. These results implied that IL-23 may be an important cytokine for the innate immune response during B. pseudomallei infection. The regulation of IL-23 production may drive the different host innate immune responses between patients and may relate to the severity of melioidosis.


Asunto(s)
Burkholderia pseudomallei/inmunología , Inmunidad Innata , Subunidad p19 de la Interleucina-23/biosíntesis , Monocitos/inmunología , Monocitos/microbiología , Células Cultivadas , Ensayo de Inmunoadsorción Enzimática , Perfilación de la Expresión Génica , Humanos , Subunidad p19 de la Interleucina-23/metabolismo , Análisis por Micromatrices , Viabilidad Microbiana
5.
Am J Trop Med Hyg ; 93(3): 542-546, 2015 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-26123956

RESUMEN

Melioidosis is a severe disease caused by the Gram-negative bacterium Burkholderia pseudomallei. Diagnosis of melioidosis currently relies on the isolation of B. pseudomallei from clinical samples, which can take several days. An indirect hemagglutination assay (IHA) is widely used for serodiagnosis, but it has a short shelf life, is poorly standardized, and requires a viable bacteria culture performed in a biosafety level 3 (BSL-3) laboratory. To improve the diagnostic methods, we have developed two rapid latex agglutination tests based on purified B. pseudomallei O-polysaccharide (OPS) and capsular polysaccharide (CPS) antigens. The immunodiagnostic potential of these tests was evaluated using serum from culture-confirmed melioidosis patients (N = 143) and healthy donors from either endemic (N = 199) or non-endemic areas (N = 90). The sensitivity of the OPS-based latex agglutination assay (OPS-latex; 84.4%) was significantly higher than both the CPS-latex (69.5%) (P < 0.001) and IHA (69.5%) (P = 0.001). When evaluated with Thai donor serum, the OPS-latex had comparable specificity (56.9%) to the CPS-latex (63.8%) (P = 0.053), but was significantly lower than the IHA (67.6%) (P = 0.002). In contrast, all tests with U.S. donor serum were highly specific (≥ 97.8%). These results suggest that polysaccharide-based latex agglutination assays may be useful for serodiagnosis of melioidosis in non-endemic areas.


Asunto(s)
Anticuerpos Antibacterianos/inmunología , Burkholderia pseudomallei/inmunología , Pruebas de Fijación de Látex/métodos , Melioidosis/diagnóstico , Polisacáridos Bacterianos/inmunología , Acetazolamida , Cápsulas Bacterianas/inmunología , Humanos , Melioidosis/inmunología , Melioidosis/microbiología , Microesferas , Sensibilidad y Especificidad , Pruebas Serológicas/métodos
6.
BMC Microbiol ; 15: 56, 2015 Mar 03.
Artículo en Inglés | MEDLINE | ID: mdl-25879538

RESUMEN

BACKGROUND: Burkholderia pseudomallei is a Gram-negative bacterium that causes melioidosis, an often fatal disease in tropical countries. Burkholderia thailandensis is a non-virulent but closely related species. Both species are soil saprophytes but are almost never isolated together. RESULTS: We identified two mechanisms by which B. pseudomallei affects the growth of B. thailandensis. First, we found that six different isolates of B. pseudomallei inhibited the growth of B. thailandensis on LB agar plates. Second, our results indicated that 55% of isolated strains of B. pseudomallei produced a secreted compound that inhibited the motility but not the viability of B. thailandensis. Analysis showed that the active compound was a pH-sensitive and heat-labile compound, likely a protein, which may affect flagella processing or facilitate their degradation. Analysis of bacterial sequence types (STs) demonstrated an association between this and motility inhibition. The active compound was produced from B. pseudomallei during the stationary growth phase. CONCLUSION: Taken together, our results indicate that B. pseudomallei inhibits both the growth and motility of its close relative B. thailandensis. The latter phenomenon appears to occur via a previously unreported mechanism involving flagellar processing or degradation.


Asunto(s)
Antibiosis , Proteínas Bacterianas/farmacología , Factores Biológicos/farmacología , Burkholderia pseudomallei/patogenicidad , Burkholderia/efectos de los fármacos , Microbiología del Suelo , Agar , Proteínas Bacterianas/química , Factores Biológicos/química , Burkholderia/crecimiento & desarrollo , Burkholderia/ultraestructura , Burkholderia pseudomallei/química , Burkholderia pseudomallei/fisiología , Medios de Cultivo/química , Medios de Cultivo Condicionados/química , Medios de Cultivo Condicionados/farmacología , Flagelos/química , Flagelos/efectos de los fármacos , Flagelos/ultraestructura , Concentración de Iones de Hidrógeno , Movimiento/efectos de los fármacos , Estabilidad Proteica , Proteolisis , Tailandia
7.
Infect Immun ; 83(5): 2127-38, 2015 May.
Artículo en Inglés | MEDLINE | ID: mdl-25776750

RESUMEN

Burkholderia pseudomallei is a CDC tier 1 select agent that causes melioidosis, a severe disease in humans and animals. Persistent infections are common, and there is currently no vaccine available. Lipopolysaccharide (LPS) is a potential vaccine candidate. B. pseudomallei expresses three serologically distinct LPS types. The predominant O-polysaccharide (OPS) is an unbranched heteropolymer with repeating d-glucose and 6-deoxy-l-talose residues in which the 6-deoxy-l-talose residues are variably replaced with O-acetyl and O-methyl modifications. We observed that primary clinical B. pseudomallei isolates with mucoid and nonmucoid colony morphologies from the same sample expressed different antigenic types distinguishable using an LPS-specific monoclonal antibody (MAb). MAb-reactive (nonmucoid) and nonreactive (mucoid) strains from the same patient exhibited identical LPS banding patterns by silver staining and indistinguishable genotypes. We hypothesized that LPS antigenic variation reflected modification of the OPS moieties. Mutagenesis of three genes involved in LPS synthesis was performed in B. pseudomallei K96243. Loss of MAb reactivity was observed in both wbiA (encoding a 2-O-acetyltransferase) and wbiD (putative methyl transferase) mutants. The structural characteristics of the OPS moieties from isogenic nonmucoid strain 4095a and mucoid strain 4095c were further investigated. Utilizing nuclear magnetic resonance (NMR) spectroscopy, we found that B. pseudomallei 4095a and 4095c OPS antigens exhibited substitution patterns that differed from the prototypic OPS structure. Specifically, 4095a lacked 4-O-acetylation, while 4095c lacked both 4-O-acetylation and 2-O-methylation. Our studies indicate that B. pseudomallei OPS undergoes antigenic variation and suggest that the 9D5 MAb recognizes a conformational epitope that is influenced by both O-acetyl and O-methyl substitution patterns.


Asunto(s)
Variación Antigénica , Burkholderia pseudomallei/crecimiento & desarrollo , Burkholderia pseudomallei/metabolismo , Antígenos O/metabolismo , Anticuerpos Antibacterianos/inmunología , Anticuerpos Monoclonales/inmunología , Burkholderia pseudomallei/química , Burkholderia pseudomallei/aislamiento & purificación , Electroforesis en Gel de Poliacrilamida , Humanos , Espectroscopía de Resonancia Magnética , Melioidosis/microbiología , Antígenos O/química , Antígenos O/inmunología , Unión Proteica
8.
Pathog Dis ; 71(1): 69-72, 2014 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-24376210

RESUMEN

Burkholderia pseudomallei is a Gram-negative intracellular bacterium and the causative agent of melioidosis. Innate immune mechanisms against this pathogen, which might contribute to outcomes of melioidosis, are little known. We demonstrated here that B. pseudomallei could activate NADPH oxidase in primary human monocytes as judged by production of reactive oxygen species (ROS) and p40(phox) phosphorylation after infection. However, as similar to other intracellular bacteria, this bacterium was able to resist and multiply inside monocytes despite being able to activate NADPH oxidase. In the presence of NADPH oxidase inhibitor, diphenyleneiodonium or apocynin, intracellular multiplication of B. pseudomallei was significantly increased, suggesting that NADPH oxidase-mediated ROS production is essential in suppressing intracellular multiplication of B. pseudomallei. Additionally, interferon-γ (IFN-γ)-mediated intracellular killing of B. pseudomallei requires NADPH oxidase activity, even though ROS level was not detected at higher levels in IFN-γ-treated infected monocytes. Altogether, these results imply that the activation of NADPH plays an essential role in suppressing intracellular multiplication of B. pseudomallei in human monocytes, although this enzyme is not sufficient to stop intracellular multiplication.


Asunto(s)
Burkholderia pseudomallei/crecimiento & desarrollo , Interacciones Huésped-Patógeno , Monocitos/enzimología , Monocitos/inmunología , NADPH Oxidasas/metabolismo , Burkholderia pseudomallei/inmunología , Células Cultivadas , Humanos , Proteínas I-kappa B/metabolismo , Monocitos/microbiología , Inhibidor NF-kappaB alfa , Fosforilación , Especies Reactivas de Oxígeno/metabolismo , Regulación hacia Arriba
9.
J Proteomics ; 75(3): 1031-42, 2012 Jan 04.
Artículo en Inglés | MEDLINE | ID: mdl-22062159

RESUMEN

Colony morphology variation of Burkholderia pseudomallei is a notable feature of a proportion of primary clinical cultures from patients with melioidosis. Here, we examined the hypothesis that colony morphology switching results in phenotypic changes associated with enhanced survival under adverse conditions. We generated isogenic colony morphology types II and III from B. pseudomallei strain 153 type I, and compared their protein expression profiles using 2D gel electrophoresis. Numerous proteins were differentially expressed, the most prominent of which were flagellin, arginine deiminase (AD) and carbamate kinase (CK), which were over-expressed in isogenic types II and III compared with parental type I. AD and CK (encoded by arcA and arcC) are components of the arginine deiminase system (ADS) which facilitates acid tolerance. Reverse transcriptase PCR of arcA and arcC mRNA expression confirmed the proteomic results. Transcripts of parental type I strain 153 arcA and arcC were increased in the presence of arginine, in a low oxygen concentration and in acid. Comparison of wild type with arcA and arcC defective mutants demonstrated that the B. pseudomallei ADS was associated with survival in acid, but did not appear to play a role in intracellular survival or replication within the mouse macrophage cell line J774A.1. These data provide novel insights into proteomic alterations that occur during the complex process of morphotype switching, and lend support to the idea that this is associated with a fitness advantage in vivo.


Asunto(s)
Proteínas Bacterianas/biosíntesis , Burkholderia pseudomallei/metabolismo , Regulación Bacteriana de la Expresión Génica/fisiología , Animales , Proteínas Bacterianas/genética , Burkholderia pseudomallei/citología , Burkholderia pseudomallei/genética , Humanos , Melioidosis/genética , Melioidosis/metabolismo , Mutación , Proteómica/métodos , ARN Bacteriano/biosíntesis , ARN Bacteriano/genética , Especificidad de la Especie
10.
Trans R Soc Trop Med Hyg ; 105(10): 598-600, 2011 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-21764093

RESUMEN

Burkholderia pseudomallei was examined after being maintained in distilled water at 25°C for 16 years. The Gram stain was atypical (pale pink cocci or coccobacilli). The estimated number of live and dead B. pseudomallei was 3.8×10(7) cells/ml and 1.4×10(5) cells/ml, respectively. A colony count on agar of 1.0×10(6) cfu/ml suggested that a proportion of cells were in a viable but non-culturable state. Colony morphology was different from the parental isolate for 84% of colonies. Pulsed-field gel electrophoresis analysis of AvrII DNA restriction fragments revealed six different but related banding patterns, which may represent genomic rearrangement.


Asunto(s)
Burkholderia pseudomallei/crecimiento & desarrollo , ADN Bacteriano/genética , Electroforesis en Gel de Campo Pulsado , Melioidosis/genética , Microbiología del Agua , Burkholderia pseudomallei/genética , Recuento de Colonia Microbiana , Medios de Cultivo , Humanos , Factores de Tiempo
11.
FEMS Immunol Med Microbiol ; 56(3): 253-9, 2009 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-19549172

RESUMEN

Burkholderia pseudomallei is a gram-negative bacillus that is the causative agent of melioidosis. We evaluated host-pathogen interaction at different levels using three separate B. pseudomallei mutants generated by insertional inactivation. One of these mutants is defective in the production of the polysaccharide side chains associated with lipopolysaccharide; one does not produce the capsular polysaccharide with the structure -3)-2-O-acetyl-6-deoxy-beta-d-manno-heptopyranose-(1-; and the third mutant does not produce flagellin. We compared the in vivo virulence in BALB/c mice, the in vitro fate of intracellular survival inside human polymorphonuclear cells (PMNs) and macrophages (Mphis) and the susceptibility to killing by 30% normal human serum, reactive nitrogen and oxygen intermediates and antimicrobial peptides with that of their wild-type counterpart. The lipopolysaccharide and capsule mutants demonstrated a marked reduction in virulence for BALB/c mice, but the flagellin mutant was only slightly less virulent than the parent strain. The results from the BALB/c mice experiments correlated with survival in Mphis. The lipopolysaccharide and capsule mutants were also more susceptible to killing by antimicrobial agents. All bacteria were equally susceptible to killing by PMNs. Altogether, the data suggest that lipopolysaccharide and capsule and, to a much lesser extent, flagella, are most likely associated with the virulence of this bacterium and highlight the importance of intracellular killing by PMNs and Mphis in disease pathogenesis.


Asunto(s)
Proteínas Bacterianas/fisiología , Burkholderia pseudomallei/patogenicidad , Factores de Virulencia/fisiología , Animales , Antibacterianos/farmacología , Péptidos Catiónicos Antimicrobianos/farmacología , Cápsulas Bacterianas/genética , Actividad Bactericida de la Sangre , Burkholderia pseudomallei/efectos de los fármacos , Burkholderia pseudomallei/inmunología , Flagelina/genética , Técnicas de Inactivación de Genes , Humanos , Lipopolisacáridos/genética , Macrófagos/microbiología , Ratones , Ratones Endogámicos BALB C , Viabilidad Microbiana , Mutagénesis Insercional , Neutrófilos/microbiología , Especies de Nitrógeno Reactivo/farmacología , Especies Reactivas de Oxígeno/farmacología , Análisis de Supervivencia , Virulencia
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...